{"id":"https://openalex.org/W2010820732","doi":"https://doi.org/10.1080/1475636032000069846","title":"Synthesis and Anti-HIV Activity of Some Heterodimers [NRTI]-Glycyl-Succinyl-[Trovirdine Analogue] of Known HIV-1 Reverse Transcriptase Inhibitors","display_name":"Synthesis and Anti-HIV Activity of Some Heterodimers [NRTI]-Glycyl-Succinyl-[Trovirdine Analogue] of Known HIV-1 Reverse Transcriptase Inhibitors","publication_year":2003,"publication_date":"2003-04-01","ids":{"openalex":"https://openalex.org/W2010820732","doi":"https://doi.org/10.1080/1475636032000069846","mag":"2010820732","pmid":"https://pubmed.ncbi.nlm.nih.gov/12943202"},"language":"en","primary_location":{"id":"doi:10.1080/1475636032000069846","doi":"https://doi.org/10.1080/1475636032000069846","is_oa":true,"landing_page_url":"https://doi.org/10.1080/1475636032000069846","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/1475636032000069846?needAccess=true&role=button","source":{"id":"https://openalex.org/S192603849","display_name":"Journal of Enzyme Inhibition and Medicinal Chemistry","issn_l":"1475-6366","issn":["1475-6366","1475-6374"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Enzyme Inhibition and Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.tandfonline.com/doi/pdf/10.1080/1475636032000069846?needAccess=true&role=button","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002195027","display_name":"Elena Sugeac","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4392021217","display_name":"Centre d'Etudes et de Recherche sur le M\u00e9dicament de Normandie","ror":"https://ror.org/012jsqx30","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210105918","https://openalex.org/I4392021217","https://openalex.org/I98702875"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Elena Sugeac","raw_affiliation_strings":["Centre d'Etudes et de Recherche sur le M\u00e9dicament de Normandie, U.F.R. des Sciences, Pharmaceutiques, 5, Rue Vaub\u00e9nard, Cedex, F-14032, Caen, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre d'Etudes et de Recherche sur le M\u00e9dicament de Normandie, U.F.R. des Sciences, Pharmaceutiques, 5, Rue Vaub\u00e9nard, Cedex, F-14032, Caen, France","institution_ids":["https://openalex.org/I4392021217"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034097866","display_name":"Christine Fossey","orcid":"https://orcid.org/0000-0001-7583-1894","observed_orcids":["https://orcid.org/0000-0001-7583-1894"]},"institutions":[{"id":"https://openalex.org/I4392021217","display_name":"Centre d'Etudes et de Recherche sur le M\u00e9dicament de Normandie","ror":"https://ror.org/012jsqx30","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210105918","https://openalex.org/I4392021217","https://openalex.org/I98702875"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Christine Fossey","raw_affiliation_strings":["Centre d'Etudes et de Recherche sur le M\u00e9dicament de Normandie, U.F.R. des Sciences, Pharmaceutiques, 5, Rue Vaub\u00e9nard, Cedex, F-14032, Caen, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre d'Etudes et de Recherche sur le M\u00e9dicament de Normandie, U.F.R. des Sciences, Pharmaceutiques, 5, Rue Vaub\u00e9nard, Cedex, F-14032, Caen, France","institution_ids":["https://openalex.org/I4392021217"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030379419","display_name":"DANIEL LADUREE","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4392021217","display_name":"Centre d'Etudes et de Recherche sur le M\u00e9dicament de Normandie","ror":"https://ror.org/012jsqx30","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210105918","https://openalex.org/I4392021217","https://openalex.org/I98702875"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Daniel Ladur\u00e9e","raw_affiliation_strings":["Centre d'Etudes et de Recherche sur le M\u00e9dicament de Normandie, U.F.R. des Sciences, Pharmaceutiques, 5, Rue Vaub\u00e9nard, Cedex, F-14032, Caen, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre d'Etudes et de Recherche sur le M\u00e9dicament de Normandie, U.F.R. des Sciences, Pharmaceutiques, 5, Rue Vaub\u00e9nard, Cedex, F-14032, Caen, France","institution_ids":["https://openalex.org/I4392021217"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054204274","display_name":"Sylvie Schmidt","orcid":"https://orcid.org/0000-0002-2114-7541","observed_orcids":["https://orcid.org/0000-0002-2114-7541"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sylvie Schmidt","raw_affiliation_strings":["I.N.S.E.R.M., 3, Rue Koeberl\u00e9, F-67000, Strasbourg, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"I.N.S.E.R.M., 3, Rue Koeberl\u00e9, F-67000, Strasbourg, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004502520","display_name":"G\u00e9raldine Laumond","orcid":"https://orcid.org/0000-0003-1867-0734","observed_orcids":["https://orcid.org/0000-0003-1867-0734"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Geraldine Laumond","raw_affiliation_strings":["I.N.S.E.R.M., 3, Rue Koeberl\u00e9, F-67000, Strasbourg, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"I.N.S.E.R.M., 3, Rue Koeberl\u00e9, F-67000, Strasbourg, France","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109925174","display_name":"Ann\u00e9-Marie Aubertin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anne-marie Aubertin","raw_affiliation_strings":["I.N.S.E.R.M., 3, Rue Koeberl\u00e9, F-67000, Strasbourg, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"I.N.S.E.R.M., 3, Rue Koeberl\u00e9, F-67000, Strasbourg, France","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5030379419"],"corresponding_institution_ids":["https://openalex.org/I4392021217"],"apc_list":{"value":1880,"currency":"GBP","value_usd":2306},"apc_paid":null,"fwci":0.1965,"has_fulltext":true,"cited_by_count":11,"citation_normalized_percentile":{"value":0.55680584,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"18","issue":"2","first_page":"175","last_page":"186"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-1-reverse-transcriptase-inhibitors","display_name":"HIV-1 reverse transcriptase inhibitors","score":0.972000002861023},{"id":"https://openalex.org/keywords/heterodimer","display_name":"heterodimer","score":0.7200000286102295},{"id":"https://openalex.org/keywords/stavudine","display_name":"stavudine","score":0.9520000219345093},{"id":"https://openalex.org/keywords/anti-hiv-activity","display_name":"anti-HIV activity","score":0.6850000023841858}],"concepts":[{"id":"https://openalex.org/C156719811","wikidata":"https://www.wikidata.org/wiki/Q28774","display_name":"Reverse transcriptase","level":4,"score":0.8870941400527954},{"id":"https://openalex.org/C2780557392","wikidata":"https://www.wikidata.org/wiki/Q523796","display_name":"Linker","level":2,"score":0.8283875584602356},{"id":"https://openalex.org/C2909970146","wikidata":"https://www.wikidata.org/wiki/Q421559","display_name":"Nucleoside Reverse Transcriptase Inhibitor","level":5,"score":0.7735718488693237},{"id":"https://openalex.org/C2777351918","wikidata":"https://www.wikidata.org/wiki/Q421559","display_name":"Reverse-transcriptase inhibitor","level":5,"score":0.6835180521011353},{"id":"https://openalex.org/C2776568683","wikidata":"https://www.wikidata.org/wiki/Q23005640","display_name":"Moiety","level":2,"score":0.6339898109436035},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5978619456291199},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.513372540473938},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.49457046389579773},{"id":"https://openalex.org/C2776543447","wikidata":"https://www.wikidata.org/wiki/Q28734","display_name":"Nucleoside","level":2,"score":0.4708639681339264},{"id":"https://openalex.org/C2777333352","wikidata":"https://www.wikidata.org/wiki/Q2689559","display_name":"Nucleoside analogue","level":3,"score":0.4597187042236328},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.43730083107948303},{"id":"https://openalex.org/C153574943","wikidata":"https://www.wikidata.org/wiki/Q408939","display_name":"Nucleotidyltransferase","level":4,"score":0.41403234004974365},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.29545995593070984},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2025156021118164},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.12226814031600952},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.07539254426956177},{"id":"https://openalex.org/C111919701","wikidata":"https://www.wikidata.org/wiki/Q9135","display_name":"Operating system","level":1,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005998","descriptor_name":"Glycine","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":true},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D019281","descriptor_name":"Dimerization","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D019802","descriptor_name":"Succinic Acid","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D020128","descriptor_name":"Inhibitory Concentration 50","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054303","descriptor_name":"HIV Reverse Transcriptase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1080/1475636032000069846","doi":"https://doi.org/10.1080/1475636032000069846","is_oa":true,"landing_page_url":"https://doi.org/10.1080/1475636032000069846","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/1475636032000069846?needAccess=true&role=button","source":{"id":"https://openalex.org/S192603849","display_name":"Journal of Enzyme Inhibition and Medicinal Chemistry","issn_l":"1475-6366","issn":["1475-6366","1475-6374"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Enzyme Inhibition and Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:12943202","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12943202","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of enzyme inhibition and medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1080/1475636032000069846","doi":"https://doi.org/10.1080/1475636032000069846","is_oa":true,"landing_page_url":"https://doi.org/10.1080/1475636032000069846","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/1475636032000069846?needAccess=true&role=button","source":{"id":"https://openalex.org/S192603849","display_name":"Journal of Enzyme Inhibition and Medicinal Chemistry","issn_l":"1475-6366","issn":["1475-6366","1475-6374"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Enzyme Inhibition and Medicinal Chemistry","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.46810001134872437,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307875","display_name":"Styrelsen f\u00f6r Internationellt Utvecklingssamarbete","ror":"https://ror.org/01fn7me06"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2010820732.pdf","grobid_xml":"https://content.openalex.org/works/W2010820732.grobid-xml"},"referenced_works_count":18,"referenced_works":["https://openalex.org/W1593383446","https://openalex.org/W1977282539","https://openalex.org/W1979092952","https://openalex.org/W1986236331","https://openalex.org/W1988263580","https://openalex.org/W2031928161","https://openalex.org/W2032026161","https://openalex.org/W2034209707","https://openalex.org/W2043791821","https://openalex.org/W2056686421","https://openalex.org/W2061803752","https://openalex.org/W2067786897","https://openalex.org/W2071313281","https://openalex.org/W2072409481","https://openalex.org/W2095460609","https://openalex.org/W2095725835","https://openalex.org/W2104378500","https://openalex.org/W2114918609"],"related_works":["https://openalex.org/W2179979309","https://openalex.org/W2063234751","https://openalex.org/W2030530075","https://openalex.org/W2286065042","https://openalex.org/W1994607156","https://openalex.org/W1559705409","https://openalex.org/W2045007367","https://openalex.org/W2091683480","https://openalex.org/W1988356299","https://openalex.org/W7132795462"],"abstract_inverted_index":{"Expected":[0],"for":[1],"their":[2],"ability":[3],"to":[4,50],"inhibit":[5],"HIV":[6],"replication,":[7],"four":[8],"heterodimers":[9],"with":[10],"a":[11,18,26,46,73],"Nucleoside":[12],"Reverse":[13,20],"Transcriptase":[14,21],"Inhibitor":[15,22],"(NRTI)":[16],"and":[17,31,39,64],"Non-Nucleoside":[19],"(NNRTI)":[23],"bound":[24],"by":[25],"linker":[27],"arm":[28],"were":[29,41],"designed":[30],"synthesized.":[32],"For":[33,43],"the":[34,44,51,59,69],"NRTIs,":[35],"d4U,":[36],"d2U,":[37],"d4T":[38],"5'-O-acetyl-5-(3-hydroxypropynyl)d2U":[40],"chosen.":[42,55],"NNRTI,":[45],"Trovirdine":[47],"Analogue":[48],"(belonging":[49],"phenethylthiazolylthiourea":[52],"class)":[53],"was":[54,66],"The":[56],"conjugation":[57],"of":[58],"two":[60],"different":[61],"inhibitors":[62],"(NRTI":[63],"NNRTI)":[65],"performed":[67],"using":[68],"succinyl-glycine":[70],"moiety":[71],"as":[72],"spontaneously":[74],"cleavable":[75],"linker.":[76]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}